发明名称 |
PHARMACEUTICAL PREPARATION CONTAINING COMPOUND EXHIBITING ANTAGONIC ACTIVITY WITH RESPECT TO ANGIOTENSIN II |
摘要 |
<p>To provide a pharmaceutical composition which performs a remarkable effect with a relatively decreased dosage, and, with less side effects, a pharmaceutical composition formulated by combination of an angiotensin II-mediated compound or a salt thereof with at least one species of a compound having the activity of increasing insulin-sensitivity, a compound having the activity of improving postprandial hyperglycemia in diabetes mellitus, an indane derivative having the activity of inhibiting angiotensin converting enzyme, a pyridine derivative having the activity of inhibiting HMG-Co A reductase or salts thereof are advantageously employed.</p> |
申请公布号 |
CZ9802886(A3) |
申请公布日期 |
1998.12.16 |
申请号 |
CZ19980002886 |
申请日期 |
1997.04.03 |
申请人 |
TAKEDA CHEMICAL INDUSTRIES |
发明人 |
TAMURA NORIKAZU;SOHDA TAKASHI;IKEDA HITOSHI |
分类号 |
A61K31/4184;A61K31/133;A61K31/41;A61K31/415;A61K31/425;A61K31/44;A61K38/04;A61K45/06;A61P3/06;A61P3/08;A61P3/10;A61P7/02;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P13/02;A61P15/00;A61P17/00;A61P25/18;A61P25/20;A61P25/24;A61P25/26;A61P25/28;A61P27/02;A61P43/00;C07D403/10;C07D413/10;C07D413/14;C07D417/10;(IPC1-7):A61K45/06 |
主分类号 |
A61K31/4184 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|